Challenger Limited (ASX:CGF) Supports APRA’s New Annuity Capital Settings
Challenger Limited (ASX:CGF) supports APRA’s new capital settings for annuities, enhancing Australia’s retirement income market.
Challenger Limited (ASX:CGF) supports APRA’s new capital settings for annuities, enhancing Australia’s retirement income market.
PYC Therapeutics (ASX:PYC) receives approval to escalate dosing in its ADOA clinical trial, advancing development of its PYC-001 drug candidate.
Radiopharm Theranostics (ASX:RAD) secures FDA Fast Track for RAD101, advancing its Phase 2 trial in brain metastases imaging.
Centrex Limited (ASX:CXM) reconvenes its second creditors meeting, proposing a DOCA by PRL Global Limited.
Syntara Limited (ASX:SNT) secures FDA Fast Track for its myelofibrosis treatment SNT-5505, accelerating its development towards becoming a new standard of care.
Cazaly Resources (ASX:CAZ) secures approval to begin drilling at Goongarrie Gold Project, advancing its exploration efforts.
Lithium Plus Minerals (ASX:LPM) retracts previous pricing information and announces new beryllium mineral discoveries at Arunta Projects.
Tivan Limited (ASX:TVN) secures $150,000 in grants for its Sandover Fluorite Project, advancing exploration in central Australia.
Dateline Resources (ASX:DTR) announces OTCQB uplisting and updates on the Colosseum Gold-REE Project, boosting US investor access.
Toys’R’Us ANZ (ASX:TOY) appoints voluntary administrators amid insolvency risks, suspending ASX trading.